@FiercePharma: Herper: Cheap Lipitor could increase health costs. Story | Follow @FiercePharma
> Activist hedge fund Elliott Advisors is tapping six pharma executives and M&A experts to stand for election to the Actelion board, stepping up pressure for major changes at Europe's biggest biotech firm. Item
> The U.K.'s cost-effectiveness watchdog recommended Merck's injectable anti-inflammatory drug Simponi after the U.S.-based manufacturer provided more information about the product. Report
> FDA issued a warning letter to Novartis on its Ciba Vision facility in Cidra, Puerto Rico, for problems with product labeling and for continuing to use contract labs even after sterility issues. News
> ProStrakan, the pharmaceutical firm that has agreed to be bought by Japan's Kyowa Hakko Kirin, narrowed its full-year loss after bouncing back from manufacturing problems. Article
> One insider at Pfizer cashed in over half his direct holdings following a recent nearly three-year high. Story
> German drug distributor Celesio's Chief Executive Fritz Oesterle, who has had a strained relationship with the company's majority shareholder, is stepping down after more than 12 years. Item
Biotech News
@FierceBiotech: Five prostate cancer diagnostics to watch. Article | Follow @FierceBiotech
@JohnCFierce: Novartis has mapped out a blockbuster future for INC424. Story | Follow @JohnCFierce
> Interview: Pfizer vaccine unit eyes adults, infectious disease. Report
> FivePrime scores $495M cancer deal with Human Genome Sciences. News
> Genfit gets up to $54M in Sanofi deal. Story
> Astellas buys out Maxygen stake in JV for $76M. News
Vaccines News
> UK and Scotland look at foot-and-mouth disease vax program. Report
> OSU finds new delivery tech for norovirus vax. Item
> Daiichi recalls Sanofi ActHIB vax in Japan. Report
> Animal data supports J&J's Alzheimer's vaccine. Story
Manufacturing News
> Hamburg: FDA needs funding to hit inspection goal. Item
> Obama administration's track/trace recommendation lacks teeth. News
> Japan pharma stocks fall; pharma aid rises. Story
> OTC cold drug prescriptions get mixed review among states. Article
> Ranbaxy's manufacturing woes make Daiichi buy a 'failure'. Item
> Obama lobbies Congress for track/trace. Story
And Finally... Unemployment and rising expenses caused 9 million Americans to lose health insurance during the past two years, according to researchers backed by a group advocating access to health care. Report